Several studies have been conducted with mixed results since our initial report of increased Parkinson's disease risk in individuals with red hair and/or red hair-associated p.R151C variant of the MC1R gene, both of which confer high melanoma risk. We performed a meta-analysis of six publications on red hair, MC1R, and Parkinson's disease. We found that red hair (pooled odds ratios = 1.68, 95% confidence intervals: 1.07, 2.64) and p.R151C (pooled odds ratios = 1.10, 95% confidence intervals: 1.00, 1.21), but not p.R160W, were associated with greater risk for Parkinson's disease. Our results support potential roles of pigmentation and its key regulator MC1R in the pathogenesis of Parkinson's disease.
Introduction
Although there is a general inverse association between cancer and Parkinson's disease (PD), 1,2 the one exception of melanoma has been well-documented, not only in patients themselves but also in their relatives. 3, 4 Little is known regarding mechanisms underlying the reciprocally increased risk of the two disparate diseases. However, efforts have been made in recent years to investigate potential genetic intersections and common pathological pathways. 2, 5 Melanoma is strongly tied to red hair/fair skin, a phenotype of loss-of-function of the melanocortin-1 receptor gene (MC1R), the key pigmentation gene. 6 Our initial investigation based on more than 120,000 US men and women demonstrated that red hair color and red hair-associated MC1R p.R151C polymorphism (rs1805007) were associated with higher risk of PD. 5 MC1R variants have since garnered considerable interest and debate over their significance in the PD and melanoma association. [7] [8] [9] [10] [11] In a case-control study based on 870 PD cases in Spain, another red hair-associated MC1R variant p.R160W (rs1805008) was found to be associated with higher PD risk. 8 However, other epidemiological studies on this topic did not support an MC1R-PD link. [9] [10] [11] In this report, we searched all literature indexed in PubMed and performed meta- This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
analyses of studies that examined the association between red hair color, MC1R p.R151C or p.R160W, two most studied MC1R loss-of-function polymorphisms, and PD risk.
Methods

Literature search and data extraction
We searched all published literature in MEDLINE via PubMed up to July 2016 that reported PD associations with hair color, MC1R variants, and amino acid changes. For inclusion in MC1R variant analyses, all studies must have reported the specific variants or amino acid changes of interest, and the relative risks (RRs) or odds ratios (ORs). We extracted information on year of study, study type and population, cases and controls population size, country origin, focus of study, PD ascertainment method, variant of interest, lower and upper confidence intervals (CIs), minor allele frequency (MAF) in PD patients and controls, model or test type, and adjustment covariates.
Statistical analyses
We used Q statistic to examine heterogeneity among the studies and the significance level was set at 0.1. We used fixed-effects models to calculate the summary ORs as no significant heterogeneity was identified (P-heterogeneity ≥0.2 for all analyses). We did not adjust for multiple comparison because the current analyses were hypothesis-driven. Publication bias was examined with the Begg and Egger tests.
Results
We identified six publications based on eight study cohorts in total from 2009 to 2016, all with study focus on hair color or MC1R p.R151C or p.R160W polymorphisms (Table 1) .
5,7-11 PD cases were of US, French/ French-Canadian, UK, German, Greek, Dutch, and Spanish origins, overall representing white populations. (Fig. 1A) . When we further examined two MC1R red hair color alleles, we found that p.R151C variant was associated with marginally increased risk of PD (pooled OR = 1.101; 95% CI: 1.002, 1.210; P = 0.046; PD case number = 8454 5,7-10 ] (Fig. 1B) . However, we did not find significant association between p.R160W and PD risk (pooled OR = 1.019; 95% CI: 0.956, 1.807; P = 0.57; PD case number = 14,934) [7] [8] [9] [10] [11] (Fig. 1C) . There was no strong evidence of publication bias based on the Begg and Egger tests (P > 0.05 for all).
Discussion
In this meta-analysis of six publications, totaling eight study cohorts, 5,7-11 we found that red hair color was significantly associated with higher risk for PD. Red hairassociated MC1R variant p.R151C had a significant association with PD risk. Another red hair color variant, p.R160W, was not associated with PD risk.
The associations of red hair color and MC1R p.R151C with PD risk are consistent with our initial report. 5 Skin/ hair color is determined by relative production of brownblack eumelanin and yellow-red pheomelanin. Binding to its ligand a-melanocyte-stimulating hormone, the G protein-coupled MC1R induces synthesis of eumelanin through cAMP cascade. 6, 12 Loss-of-function MC1R variants including p.R151C facilitate pheomelanin formation and are associated with red hair/fair skin and increased risk of melanoma. 6, 12, 13 MC1R is also involved in the regulation of other cellular functions independent of pigmentation. 12 Evidence supports a critical role of pheomelanin as a prooxidant in MC1R melanomagenesis, 6 and involvement of red hair pigmentation in PD is supported by our original report 5 and the present metaanalysis. Other studies have also implicated a potential role of general pigmentation in PD. For example, primary skin cultures from individuals with red hair color showed deregulation of genes involved in neurodegenerative diseases such as PD.
14 A clinical study reported a correlation between light pigmentation phenotype and increased echogenicity of the substantia nigra. 15 Furthermore, a GWA study identified melanogenesis as significant pathways for PD. 16 However, it is not clear whether skin/hair pigmentation accounts all or in part for MC1R p.R151C-PD association.
Interestingly, despite limited knowledge about its biosynthetic pathway and its exact role in dopaminergic neuron degeneration, neuromelanin, the third melanin in humans in fact has a pheomelanin core and a eumelanin surface. 17 This finding has led to a hypothesis that thinning eumelanin surface and exposing pheomelanin core may be responsible for the selective vulnerability of pigmented dopaminergic neurons in PD. 18 Although early evidence supports expression of MC1R in brain, 19 and MC1R has been proposed to be neuroprotective, 8 it remains to be determined whether MC1R signaling plays any role in the synthesis and functions of neuromelanin and how neuromelanin is related to peripheral pigmentation, that is, skin/hair color.
MC1R p.R160W, another red hair-associated polymorphism that was associated with higher PD risk in one study with a Spanish population, 8 did not show a significant positive association in our meta-analysis. One of the difficulties in ascertaining the association stems from the relatively low MAF and penetrance of MC1R in both PD and non-PD patients 5,7-11 compared to other PD predisposing genes such as those of the family of PARK genes, though the frequency of MC1R mutations is comparable to those of melanoma cases. 6, 12 Furthermore, the frequency of minor alleles differs between populations, 20 and possible differential biological mechanisms and environmental interactions contributing to the mixed evidence for the association with PD should be clarified.
Although our original findings 5 are generally supported by this meta-analysis, larger, prospective cohorts with different ethnic backgrounds are needed to verify the associations between hair color, p.R151C, and possibly other MC1R red hair variants and PD risk. In addition, laboratory studies would provide critical insight into the mechanistic roles of MC1R and pigmentation in dopaminergic neuron degeneration in PD.
